111 related articles for article (PubMed ID: 7331388)
21. Health-related quality of life after revascularization for peripheral arterial occlusive disease: long-term follow-up.
Wann-Hansson C; Hallberg IR; Risberg B; Lundell A; Klevsgard R
J Adv Nurs; 2005 Aug; 51(3):227-35. PubMed ID: 16033590
[TBL] [Abstract][Full Text] [Related]
22. [Ambulatory, CT-assisted lumbar sympathicolysis in patients with severe peripheral artery disease: influence on peripheral blood flow and clinical outcome].
Nickel J; Brinckmann W; Andresen R
Zentralbl Chir; 2008 Aug; 133(4):349-54. PubMed ID: 18702019
[TBL] [Abstract][Full Text] [Related]
23. Haemodilution in patients with peripheral arterial occlusive disease.
Kiesewetter H; Jung F; Erdlenbruch W; Wenzel E
Int Angiol; 1992; 11(3):169-75. PubMed ID: 1281205
[TBL] [Abstract][Full Text] [Related]
24. [Physical therapy in peripheral arterial circulatory disorders].
Köhler M
Z Allgemeinmed; 1974 Jul; 50(21):952-6. PubMed ID: 4849397
[No Abstract] [Full Text] [Related]
25. [Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].
Battke K; Buchwalsky R; Barmeyer J; Hoffmann G; Reindell H
Fortschr Med; 1978 Jul; 96(26-27):1381-6. PubMed ID: 669532
[No Abstract] [Full Text] [Related]
26. [The treatment of distal arterial disorders].
van Vroonhoven TJ; Eikelboom BC
Ned Tijdschr Geneeskd; 1994 Oct; 138(42):2089-92. PubMed ID: 7969574
[No Abstract] [Full Text] [Related]
27. [Treatment strategies in arterial occlusive diseases].
Bollinger A
Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1354-8. PubMed ID: 8272701
[TBL] [Abstract][Full Text] [Related]
28. [Hemodilution in peripheral arterial occlusive disease].
Becsi C; Wehofer D; Weidinger P
Vasa Suppl; 1988; 26():113-5. PubMed ID: 2462284
[No Abstract] [Full Text] [Related]
29. [Hypervolemic hemodilution with bloodletting in patients with peripheral arterial occlusive disease].
Kiesewetter H; Blume HJ; Jung F; Bach R; Spitzer S; Leipnitz G; Schieffer H; Bette L; Wenzel E
Vasa Suppl; 1988; 26():107-12. PubMed ID: 2462283
[No Abstract] [Full Text] [Related]
30. [10 minute consultation: intermittent claudication].
Rieger H
MMW Fortschr Med; 2004 Apr; 146(18):62-3. PubMed ID: 15366482
[No Abstract] [Full Text] [Related]
31. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.
Riccioni C; Sarcinella R; Palermo G; Izzo A; Liguori M; Koverech A; Messano M; Virmani A
Int Angiol; 2008 Jun; 27(3):253-9. PubMed ID: 18506129
[TBL] [Abstract][Full Text] [Related]
33. Increase in leg blood-flow by normovolaemic haemodilution in intermittent claudication.
Yates CJ; Berent A; Andrews V; Dormandy JA
Lancet; 1979 Jul; 2(8135):166-8. PubMed ID: 89279
[TBL] [Abstract][Full Text] [Related]
34. [Peripheral arterial disease: where are we in 2006?].
Sraieb T; Bougamra S; Ben Romdhane N; Longo S; Manaa J
Tunis Med; 2007 May; 85(5):361-6. PubMed ID: 17657918
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of peripheral arterial occlusive disorders with rheologically active measures].
Turowski A; Schmidt HH; Sternitzky R
Z Arztl Fortbild (Jena); 1987; 81(17):883-8. PubMed ID: 3439205
[No Abstract] [Full Text] [Related]
36. The effect of isovolaemic haemodilution and intravenous glycerol on the sequelae of middle cerebral artery occlusion in the rat.
Dietis A; Ehteshami S; Harrison MJ; Perinpanayagam NI
J Neurol Neurosurg Psychiatry; 1986 Apr; 49(4):428-30. PubMed ID: 3701352
[TBL] [Abstract][Full Text] [Related]
37. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
Kakkos SK; Geroulakos G; Nicolaides AN
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
[TBL] [Abstract][Full Text] [Related]
38. [Hemodilution therapy of arterial occlusive diseases using hydroxyethyl starch 200/0,5].
Müller-Bühl U; Comberg HU; Diehm C; Allenberg J; Mörl H
MMW Munch Med Wochenschr; 1982 Mar; 124(10):241-3. PubMed ID: 6178019
[No Abstract] [Full Text] [Related]
39. [Effect of transient therapeutic occlusion on some hemodynamic parameters and walking distance].
Acevedo A; Schoop W; Neuerburg-Heusler D; Froek K; Fronek A
Wien Med Wochenschr; 1993; 143(7-8):158-60. PubMed ID: 8379165
[TBL] [Abstract][Full Text] [Related]
40. [Clinical picture and therapy of peripheral arterial diseases].
Schoop W
Med Welt; 1974 Jul; 25(27-28):1189-93. PubMed ID: 4408927
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
